References
Kvien TK, Glennas A, Melby K, et al.: Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol 1994, 21:115–122.
Zeidler H, Kuipers J, Köhler L: Chlamydia-induced arthritis. Curr Opin Rheumatol 2004, 16:380–392.
Carter JD, Valeriano J, Vasey FB: Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 2004, 31:1973–1980.
Gerard HC, Branigan PJ, Schumacher HR, Hudson AP: Synovial Chlamydia trachom atis in patients with reactive arthritis/Reiter’s syndrome are viable but show aberrant gene expression. J. Rheumatol 1998, 25:734–742.
Gerard HC, Whittum-Hudson JA, Schumacher HR, Hudson AP: Synovial Chlamydia trachom atis up-regulates expression of a panel of genes similar to that transcribed by Mycobacterium tuberculosis during persistent infection. Ann Rheum Dis 2006, 65:321–7.
Rihl M, Köhler L, Klos A, Zeidler H: Persistent infection of Chlamydia in reactive arthritis. Ann Rheum Dis 2006, 65:281–284.
Hess S, Rheinheimer C, Tidow F, et al.: The reprogrammed host: Chlamydia trachom atis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiap optotic genes. Arthritis Rheum 2001, 44:2392–2401.
Ren Q, Robertson SJ, Howe D, et al.: Comparative DNA microarray analysis of host cell transcriptional responses to infection by Coxiella burnetii or Chlamydia trachomatis. Ann N Y Acad Sci 2003, 990:701–713.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rihl, M., Zeidler, H. The molecular pathogenesis of Chlamydia-induced arthritis: Where do we stand?. Curr Rheumatol Rep 9, 4–5 (2007). https://doi.org/10.1007/s11926-007-0015-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11926-007-0015-0